Dr. Henning Willers is an Associate Professor of Radiation Oncology at HMS and MGH. He has researched in radiation biology since 1991 and as a laboratory-based PI since 2005. His basic and translational research activities are directed at furthering our understanding of how NSCLCs respond to radiation and radiosensitizing drugs. Specifically, we seek to identify the signaling pathways that contribute to the radioresistance of KRAS-mutant lung adenocarcinoma which is an emerging clinical problem.